| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| BIOPREMIER Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EPIGENOMICS | 0,870 | 0,00 % | PTA-PVR: Epigenomics AG: Veröffentlichung nach § 40 Abs. 1 WpHG | DJ PTA-PVR: Epigenomics AG: Veröffentlichung nach § 40 Abs. 1 WpHG
Veröffentlichung gem. -- 40 Abs. 1 WpHG
Epigenomics AG: Veröffentlichung nach -- 40 Abs. 1 WpHG
Heidelberg (pta000/26.10.2026/15:00... ► Artikel lesen | |
| NOVAVAX | 6,800 | -0,44 % | Novavax: Starke Zahlen - was Anleger jetzt prüfen sollten | ||
| HEIDELBERG PHARMA | 2,010 | +0,50 % | Formycon gegen Heidelberg Pharma gegen Medios: Das Biotech-Nebenwert-Duell - Formycon liegt beim Analystenbild vorn | ||
| BIOXXMED | 0,700 | -1,41 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 30.10.2026 | The following instruments on XETRA do have their last trading day on 30.10.2026Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 30.10.2026ISIN NameDE000A41YD32 BIOXXMED AG INH O.N.DE000HLB78G8... ► Artikel lesen | |
| VIVOSIM LABS | 0,264 | +1,19 % | VivoSim Labs (VIVS) Stock Jumps 21% After Hours: What's Driving the Move | ||
| COSCIENS BIOPHARMA | 5,150 | +0,59 % | COSCIENS Biopharma Inc. Q3 Loss Widens | ||
| BIOCRYST PHARMACEUTICALS | 6,580 | -0,27 % | BioCryst Pharmaceuticals, Inc.: BioCryst Announces Formation of Scientific Advisory Board to Drive Rare Disease Pipeline Innovation and Growth | -Supports BioCryst's evolution toward a more disciplined R&D model centered on external innovation- RESEARCH TRIANGLE PARK, N.C., Oct. 05, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:... ► Artikel lesen | |
| EXELIXIS | 58,98 | +0,03 % | Where Will Exelixis Be in 5 Years? 1 Experimental Drug Could Change Everything | ||
| SAREPTA THERAPEUTICS | 12,260 | +0,82 % | Sarepta Therapeutics auf Guggenheim-Konferenz: Starker Cashflow finanziert breite Entwicklungspipeline | ||
| GERON | 0,800 | +0,98 % | Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| ARBUTUS BIOPHARMA | 3,660 | 0,00 % | Arbutus Biopharma Corporation: Arbutus Announces Final Results of Its US$230 Million Modified "Dutch Auction" Tender Offer | WARMINSTER, Pa., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company focused on infectious disease... ► Artikel lesen | |
| AMYRIS | - | - | Sugar replacement maker Oobli acquired by biotech firm Amyris | ||
| MICROBOT MEDICAL | 0,602 | -2,59 % | Citizens lowers Microbot Medical stock price target on weak Q3 results | ||
| MOSAIC IMMUNOENGINEERING | - | - | Mosaic ImmunoEngineering Inc. - 10-Q, Quarterly Report | ||
| PALISADE BIO | 0,840 | 0,00 % | "Haben keine Ahnung, was sie anrichten" - Sohn von Hamas-Gründer warnt vor Pali-Aktivisten |